COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 953: Articles 9521-9530  | Next

Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunisation Stress-related Responses with COVID-19 mRNA Vaccine
Imai, K., Tanaka, F., Kawano, S., Esaki, K., Arakawa, J., Nishiyama, T., Seno, S., Hatanaka, K., Sugiura, T., Kodama, Y., Yamada, S., Iwamoto, S., Takesima, S., Abe, N., Kamae, C., Aono, S., Ito, T., Yamamoto, T., Mizuguchi, Y.
10.1101/2022.01.12.22269134 — Posted: 2022-01-13
Assessing and improving the validity of COVID-19 autopsy studies - a multi center approach to establish essential standards for immunohistochemical and ultrastructural analyses
Krasemann, S., Dittmayer, C., v. Stillfried, S., Meinhardt, J., Heinrich, F., Hartmann, K., Pfefferle, S., Thies, E., v. Manitius, R., Aschman, T., Radke, J., Osterloh, A., Schmid, S., Buhl, E. M., Ihlow, J., Elezkurtaj, S., Horst, D., Hocke, A. C., Timm, S., Bachmann, S., Corman, V., Goebel, H.-H., Matschke, J., Stanelle-Bertram, S., Gabriel, G., Seilhean, D., Adle-Biassette, H., Ondruschka, B., Ochs, M., Stenzel, W., Heppner, F., Boor, P., Radbruch, H., Laue, M., Glatzel, M.
10.1101/2022.01.13.22269205 — Posted: 2022-01-13
Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines' efficacy
Ren, Z., Nishimura, M., Tjan, L. H., Furukawa, K., Kurahashi, Y., Sutandhio, S., Aoki, K., Hasegawa, N., Arii, J., Uto, K., Matsui, K., Sato, I., Saegusa, J., Godai, N., Takeshita, K., Yamamoto, M., Nagashima, T., Mori, Y.
10.1101/2022.01.13.22269203 — Posted: 2022-01-13
Evidence of early community transmission of Omicron (B1.1.529) in Delhi- A city with very high seropositivity and past exposure!
Garg, R., Gautam, P., Suroliya, V., Agarwal, R., Bhugra, A., Kaur, U. S., Das, S., Bihari, C., Agarwal, A., Sarin, S. K., Gupta, E.
10.1101/2022.01.10.22269041 — Posted: 2022-01-13
Seasonal Prediction of Omicron Pandemic
Huang, J., Zhao, Y., Zhang, L., Li, X., Gao, S., Song, X.
10.1101/2022.01.13.22269198 — Posted: 2022-01-13
Application of the Logistic Model to the COVID-19 Pandemic in South Africa and the United States: Correlations and Predictions
Roberts, D. H.
10.1101/2022.01.12.22269193 — Posted: 2022-01-13
Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
Rodda, L. B., Morawski, P. A., Pruner, K. B., Fahning, M. L., Howard, C. A., Franko, N., Logue, J., Eggenberger, J., Stokes, C., Golez, I., Hale, M., Gale, M., Chu, H. Y., Campbell, D. J., Pepper, M.
10.1101/2022.01.12.22269192 — Posted: 2022-01-13
COVID infection severity in children under 5 years old before and after Omicron emergence in the US
Wang, L., Berger, N. A., Kaelber, D. C., Davis, P. B., Volkow, N. D., Xu, R.
10.1101/2022.01.12.22269179 — Posted: 2022-01-13
Rapid and Accurate Identification of SARS-CoV-2 Omicron Variants Using Droplet Digital PCR (RT-ddPCR)
Mills, M., Hajian, P., Bakhash, S. M., Xie, H., Mantzke, D., Zhu, H., Huang, M., Pepper, G., Jerome, K., Roychoudhury, P., Greninger, A.
10.1101/2022.01.11.22268981 — Posted: 2022-01-12
Favipiravir, umifenovir and camostat mesylate: a comparative study against SARS-CoV-2
Unal, M. A., Besbinar, O., Nazir, H., Summak, G. Y., Bayrakdar, F., Delogu, L. G., Taskin, T., Ozkan, S. A., Akcali, K. C., Yilmazer, A.
10.1101/2022.01.11.475889 — Posted: 2022-01-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).